Polymer‐free Biolimus‐A9 coated thin strut stents for patients at high bleeding risk 1‐year results from the LEADERS FREE III study

BACKGROUND: In patients at high bleeding risk (HBR), the LEADERS FREE (LF) trial established the safety and efficacy of a polymer‐free drug coated (Biolimus‐A9) stainless steel stent (SS‐DCS) with 30 days of dual antiplatelet treatment (DAPT). In LEADERS FREE III, we studied a new cobalt‐chromium th...

Descripción completa

Detalles Bibliográficos
Autores principales: Eberli, Franz R., Stoll, Hans‐Peter, Urban, Philip, Morice, Marie‐Claude, Brunel, Philippe, Maillard, Luc, Lipiecki, Janus, Cook, Stephane, Berland, Jacques, Hovasse, Thomas, Carrie, Didier, Schütte, Diana, Slama, Sara Sadozai, Garot, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544800/
https://www.ncbi.nlm.nih.gov/pubmed/34241947
http://dx.doi.org/10.1002/ccd.29869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544800/
https://www.ncbi.nlm.nih.gov/pubmed/34241947
http://dx.doi.org/10.1002/ccd.29869

Ejemplares similares